ORIC — ORIC PHARMACEUTICALS INC

Ownership history in EcoR1 Capital, LLC  ·  23 quarters on record

This page tracks every 13F SEC filing in which EcoR1 Capital, LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.58% (2020 Q2)
Avg. % of fund
1.91%
First filed
2020 Q2
Last filed
2025 Q4
Quarters held
23
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 6,728,116 — 0% 2.50% $55.0M $8.18
2025 Q3 ADDED 6,728,116 +5,110,048 +315.8% 3.87% $80.7M $12.00
2025 Q2 REDUCED 1,618,068 -1,800,000 -52.7% 0.97% $16.4M $10.15
2025 Q1 UNCHANGED 3,418,068 — 0% 1.13% $19.1M $5.58
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 1.27%
← Back to EcoR1 Capital, LLC Holdings